Quanterix Corp balance sheet
At the end of fiscal 2025, Quanterix Corp had total assets of $419m, total liabilities of $123m and shareholders' equity of $296m. It held $29.8m in cash against $0 of debt.
Balance sheet
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 30 | 80 | 44 | 109 | 182 | 396 | 339 | 174 | 57 | 30 | 44 |
| Receivables | — | 6 | 7 | 11 | 17 | 24 | 19 | 25 | 32 | 30 | 22 |
| Inventory | — | 4 | 6 | 10 | 15 | 22 | 17 | 26 | 33 | 55 | 48 |
| Total current assets | — | 89 | 59 | 133 | 220 | 449 | 382 | 382 | 364 | 212 | 171 |
| Goodwill | — | — | 1 | 9 | 10 | 10 | 0 | 0 | 0 | 26 | 0 |
| Total assets | — | 92 | 68 | 170 | 271 | 502 | 434 | 429 | 407 | 419 | 320 |
| Accounts payable | — | 4 | 5 | 6 | 7 | 9 | 4 | 5 | 7 | 14 | 9 |
| Deferred revenue (current) | — | 5 | 5 | 5 | 5 | 6 | 9 | 9 | 9 | 21 | 15 |
| Total current liabilities | — | 20 | 18 | 20 | 40 | 37 | 31 | 39 | 42 | 75 | 50 |
| Short-term debt | — | 5 | — | 0 | 8 | — | — | — | — | — | — |
| Long-term debt | — | 4 | 8 | 8 | 8 | — | — | — | — | — | — |
| Total debt | 0 | 9 | 8 | 8 | 8 | 2 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | 26 | 27 | 41 | 65 | 61 | 76 | 79 | 76 | 123 | 82 |
| Shareholders' equity | −115 | 66 | 41 | 129 | 206 | 443 | 358 | 350 | 330 | 296 | 237 |
| Shares outstanding | — | — | 22m | 28m | 32m | 37m | 37m | 38m | 39m | 47m | 47m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 31 | 32 | 28 | 24 | 33 | 30 | 27 | 22 |
| Inventory | 33 | 33 | 31 | 30 | 55 | 55 | 51 | 48 |
| Total current assets | 367 | 364 | 335 | 322 | 233 | 212 | 186 | 171 |
| Goodwill | — | 0 | 7 | 0 | 23 | 26 | 27 | 0 |
| Total assets | 411 | 407 | 397 | 376 | 444 | 419 | 367 | 320 |
| Accounts payable | 6 | 7 | 7 | 9 | 11 | 14 | 9 | 9 |
| Deferred revenue (current) | 9 | 9 | 9 | 9 | 21 | 21 | 15 | 15 |
| Total current liabilities | 36 | 42 | 40 | 48 | 77 | 75 | 50 | 50 |
| Total liabilities | 72 | 76 | 80 | 83 | 130 | 123 | 85 | 82 |
| Shareholders' equity | 339 | 330 | 316 | 292 | 315 | 296 | 282 | 237 |
| Shares outstanding | 38m | 39m | 39m | 39m | 47m | 47m | 47m | 47m |
Compare with peers
- Pacific Biosciences Of California, Inc. balance sheet
- Grail, Inc. balance sheet
- Cryoport, Inc. balance sheet
- Cytek Biosciences, Inc. balance sheet
- Maravai Lifesciences Holdings, Inc. balance sheet
Head to head: PACB vs QTRXGRAL vs QTRXCYRX vs QTRX
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies